Viewing Study NCT06960395

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-02-02 @ 5:14 AM
Study NCT ID: NCT06960395
Status: RECRUITING
Last Update Posted: 2025-08-06
First Post: 2025-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Sponsor: Vir Biotechnology, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor Malignancies View
None EGFR Positive Solid Tumors View
None EGFR View
Keywords:

Keywords

Keyword Brief Keyword Text View
None VIR-5525 View